Jessica Tassan
Stock Analyst at Piper Sandler
(1.17)
# 3,780
Out of 5,090 analysts
78
Total ratings
32.31%
Success rate
-10.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Overweight | $13 → $25 | $17.18 | +45.52% | 7 | Nov 26, 2025 | |
| HNGE Hinge Health | Reiterates: Overweight | $70 → $71 | $49.66 | +42.97% | 2 | Nov 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $423 → $417 | $333.49 | +25.04% | 9 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $20.55 | +65.45% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $4.01 | +348.88% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $2.68 | +49.25% | 12 | Aug 27, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $36.95 | +132.75% | 3 | Aug 15, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $51.31 | +34.48% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $253.02 | +7.50% | 4 | Jul 31, 2025 | |
| AMWL American Well | Reiterates: Neutral | $10 → $8 | $4.12 | +94.17% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $268.42 | +39.33% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $72 → $74 | $76.75 | -3.58% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $19.37 | +8.44% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $7.78 | +54.24% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $39.54 | +77.06% | 4 | Aug 2, 2023 |
Oscar Health
Nov 26, 2025
Upgrades: Overweight
Price Target: $13 → $25
Current: $17.18
Upside: +45.52%
Hinge Health
Nov 5, 2025
Reiterates: Overweight
Price Target: $70 → $71
Current: $49.66
Upside: +42.97%
UnitedHealth Group
Oct 29, 2025
Maintains: Overweight
Price Target: $423 → $417
Current: $333.49
Upside: +25.04%
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $20.55
Upside: +65.45%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $4.01
Upside: +348.88%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $2.68
Upside: +49.25%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $36.95
Upside: +132.75%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $51.31
Upside: +34.48%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $253.02
Upside: +7.50%
American Well
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $4.12
Upside: +94.17%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $268.42
Upside: +39.33%
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $76.75
Upside: -3.58%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $19.37
Upside: +8.44%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.78
Upside: +54.24%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $39.54
Upside: +77.06%